AIP, Jo-1 and ECMO
CT scan of the chest showed features consistent with ARDS (Acute Respiratory Distress Syndrome) (figure 1B). There are reports of the successful use of all these therapies in ASSD-ILD,2–7 although the evidence is generally limited to case series. [...]we have had some success using these drugs, in o...
Gespeichert in:
| Veröffentlicht in: | Thorax 2018-12, Vol.73 (12), p.1190-1192 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1192 |
|---|---|
| container_issue | 12 |
| container_start_page | 1190 |
| container_title | Thorax |
| container_volume | 73 |
| creator | Vijayasingam, Anitha Alcalde, Inmaculada Shah, Sachin Singer, Ben Bastin, Anthony Chikanza, Ian Cordingley, Jeremy Thomas, Gavin |
| description | CT scan of the chest showed features consistent with ARDS (Acute Respiratory Distress Syndrome) (figure 1B). There are reports of the successful use of all these therapies in ASSD-ILD,2–7 although the evidence is generally limited to case series. [...]we have had some success using these drugs, in other patients with less severe ASSD-ILD. Screening for ANA, anti Cyclic citrullinated peptides (anti-CCP) and autoantibodies, including antisynthetase and myositis-associated antibodies, in all patients presenting with unexplained severe respiratory failure recalcitrant to initial therapy may help in diagnosis, as peripheral clinical signs of systemic rheumatic diseases can be very subtle. S9 Acute inflammatory presentation associates with survival in interstitial lung disease and extracorporeal membrane oxygenation-requiring severe respiratory failure: a single centre case series. |
| doi_str_mv | 10.1136/thoraxjnl-2018-212145 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2148767180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2148767180</sourcerecordid><originalsourceid>FETCH-LOGICAL-b425t-54dc62bf64edcfb3cd62260c82edeebf1adcff34281324ce69dafacaf6c970a03</originalsourceid><addsrcrecordid>eNqNkE1Lw0AQhhdRbKxevCsBr67O7G4222MpVSuVetDzstkPNLRJ3SSg_96U1J49DQzP-w7zEHKFcIfI5X37UUfzXVZrygAVZchQZEckQSEV5Wwij0kCIIBKnssROWuaEgAUYn5KRhw4y7mAhFxOF6-36XNNMTWVS-ezl9U5OQlm3fiL_RyT94f52-yJLlePi9l0SQvBspZmwlnJiiCFdzYU3DrJmASrmHfeFwFNvw5cMIWcCevlxJlgrAnSTnIwwMfkZujdxvqr802ry7qLVX9S97-oXOaodlQ2UDbWTRN90Nv4uTHxRyPonQl9MKF3JvRgos9d79u7YuPdIfX3eg_AABSb8p-dv8staQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2148767180</pqid></control><display><type>article</type><title>AIP, Jo-1 and ECMO</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Vijayasingam, Anitha ; Alcalde, Inmaculada ; Shah, Sachin ; Singer, Ben ; Bastin, Anthony ; Chikanza, Ian ; Cordingley, Jeremy ; Thomas, Gavin</creator><creatorcontrib>Vijayasingam, Anitha ; Alcalde, Inmaculada ; Shah, Sachin ; Singer, Ben ; Bastin, Anthony ; Chikanza, Ian ; Cordingley, Jeremy ; Thomas, Gavin</creatorcontrib><description>CT scan of the chest showed features consistent with ARDS (Acute Respiratory Distress Syndrome) (figure 1B). There are reports of the successful use of all these therapies in ASSD-ILD,2–7 although the evidence is generally limited to case series. [...]we have had some success using these drugs, in other patients with less severe ASSD-ILD. Screening for ANA, anti Cyclic citrullinated peptides (anti-CCP) and autoantibodies, including antisynthetase and myositis-associated antibodies, in all patients presenting with unexplained severe respiratory failure recalcitrant to initial therapy may help in diagnosis, as peripheral clinical signs of systemic rheumatic diseases can be very subtle. S9 Acute inflammatory presentation associates with survival in interstitial lung disease and extracorporeal membrane oxygenation-requiring severe respiratory failure: a single centre case series.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2018-212145</identifier><identifier>PMID: 30327340</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibodies, Antinuclear ; Antigens ; Autoantigens - immunology ; Cyclophosphamide - therapeutic use ; Extracorporeal Membrane Oxygenation ; Female ; Humans ; Immunoglobulins ; Immunosuppressive Agents - therapeutic use ; Intensive care ; Lung diseases ; Lung Diseases, Interstitial - etiology ; Lung Diseases, Interstitial - therapy ; Medical imaging ; Medical prognosis ; Middle Aged ; Myositis - blood ; Myositis - complications ; Myositis - diagnosis ; Myositis - drug therapy ; Ostomy ; Oxygen Inhalation Therapy ; Patients ; Pneumonia ; Respiratory Insufficiency - etiology ; Respiratory Insufficiency - therapy ; Respiratory therapy ; Rheumatology ; Ribonucleoproteins - immunology ; Rituximab - therapeutic use ; SS-B Antigen ; Tacrolimus - therapeutic use ; Ventilators</subject><ispartof>Thorax, 2018-12, Vol.73 (12), p.1190-1192</ispartof><rights>Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2018 Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b425t-54dc62bf64edcfb3cd62260c82edeebf1adcff34281324ce69dafacaf6c970a03</citedby><cites>FETCH-LOGICAL-b425t-54dc62bf64edcfb3cd62260c82edeebf1adcff34281324ce69dafacaf6c970a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30327340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vijayasingam, Anitha</creatorcontrib><creatorcontrib>Alcalde, Inmaculada</creatorcontrib><creatorcontrib>Shah, Sachin</creatorcontrib><creatorcontrib>Singer, Ben</creatorcontrib><creatorcontrib>Bastin, Anthony</creatorcontrib><creatorcontrib>Chikanza, Ian</creatorcontrib><creatorcontrib>Cordingley, Jeremy</creatorcontrib><creatorcontrib>Thomas, Gavin</creatorcontrib><title>AIP, Jo-1 and ECMO</title><title>Thorax</title><addtitle>Thorax</addtitle><description>CT scan of the chest showed features consistent with ARDS (Acute Respiratory Distress Syndrome) (figure 1B). There are reports of the successful use of all these therapies in ASSD-ILD,2–7 although the evidence is generally limited to case series. [...]we have had some success using these drugs, in other patients with less severe ASSD-ILD. Screening for ANA, anti Cyclic citrullinated peptides (anti-CCP) and autoantibodies, including antisynthetase and myositis-associated antibodies, in all patients presenting with unexplained severe respiratory failure recalcitrant to initial therapy may help in diagnosis, as peripheral clinical signs of systemic rheumatic diseases can be very subtle. S9 Acute inflammatory presentation associates with survival in interstitial lung disease and extracorporeal membrane oxygenation-requiring severe respiratory failure: a single centre case series.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibodies, Antinuclear</subject><subject>Antigens</subject><subject>Autoantigens - immunology</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Extracorporeal Membrane Oxygenation</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Intensive care</subject><subject>Lung diseases</subject><subject>Lung Diseases, Interstitial - etiology</subject><subject>Lung Diseases, Interstitial - therapy</subject><subject>Medical imaging</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Myositis - blood</subject><subject>Myositis - complications</subject><subject>Myositis - diagnosis</subject><subject>Myositis - drug therapy</subject><subject>Ostomy</subject><subject>Oxygen Inhalation Therapy</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Respiratory Insufficiency - etiology</subject><subject>Respiratory Insufficiency - therapy</subject><subject>Respiratory therapy</subject><subject>Rheumatology</subject><subject>Ribonucleoproteins - immunology</subject><subject>Rituximab - therapeutic use</subject><subject>SS-B Antigen</subject><subject>Tacrolimus - therapeutic use</subject><subject>Ventilators</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkE1Lw0AQhhdRbKxevCsBr67O7G4222MpVSuVetDzstkPNLRJ3SSg_96U1J49DQzP-w7zEHKFcIfI5X37UUfzXVZrygAVZchQZEckQSEV5Wwij0kCIIBKnssROWuaEgAUYn5KRhw4y7mAhFxOF6-36XNNMTWVS-ezl9U5OQlm3fiL_RyT94f52-yJLlePi9l0SQvBspZmwlnJiiCFdzYU3DrJmASrmHfeFwFNvw5cMIWcCevlxJlgrAnSTnIwwMfkZujdxvqr802ry7qLVX9S97-oXOaodlQ2UDbWTRN90Nv4uTHxRyPonQl9MKF3JvRgos9d79u7YuPdIfX3eg_AABSb8p-dv8staQU</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Vijayasingam, Anitha</creator><creator>Alcalde, Inmaculada</creator><creator>Shah, Sachin</creator><creator>Singer, Ben</creator><creator>Bastin, Anthony</creator><creator>Chikanza, Ian</creator><creator>Cordingley, Jeremy</creator><creator>Thomas, Gavin</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201812</creationdate><title>AIP, Jo-1 and ECMO</title><author>Vijayasingam, Anitha ; Alcalde, Inmaculada ; Shah, Sachin ; Singer, Ben ; Bastin, Anthony ; Chikanza, Ian ; Cordingley, Jeremy ; Thomas, Gavin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b425t-54dc62bf64edcfb3cd62260c82edeebf1adcff34281324ce69dafacaf6c970a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibodies, Antinuclear</topic><topic>Antigens</topic><topic>Autoantigens - immunology</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Extracorporeal Membrane Oxygenation</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Intensive care</topic><topic>Lung diseases</topic><topic>Lung Diseases, Interstitial - etiology</topic><topic>Lung Diseases, Interstitial - therapy</topic><topic>Medical imaging</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Myositis - blood</topic><topic>Myositis - complications</topic><topic>Myositis - diagnosis</topic><topic>Myositis - drug therapy</topic><topic>Ostomy</topic><topic>Oxygen Inhalation Therapy</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Respiratory Insufficiency - etiology</topic><topic>Respiratory Insufficiency - therapy</topic><topic>Respiratory therapy</topic><topic>Rheumatology</topic><topic>Ribonucleoproteins - immunology</topic><topic>Rituximab - therapeutic use</topic><topic>SS-B Antigen</topic><topic>Tacrolimus - therapeutic use</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vijayasingam, Anitha</creatorcontrib><creatorcontrib>Alcalde, Inmaculada</creatorcontrib><creatorcontrib>Shah, Sachin</creatorcontrib><creatorcontrib>Singer, Ben</creatorcontrib><creatorcontrib>Bastin, Anthony</creatorcontrib><creatorcontrib>Chikanza, Ian</creatorcontrib><creatorcontrib>Cordingley, Jeremy</creatorcontrib><creatorcontrib>Thomas, Gavin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vijayasingam, Anitha</au><au>Alcalde, Inmaculada</au><au>Shah, Sachin</au><au>Singer, Ben</au><au>Bastin, Anthony</au><au>Chikanza, Ian</au><au>Cordingley, Jeremy</au><au>Thomas, Gavin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AIP, Jo-1 and ECMO</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2018-12</date><risdate>2018</risdate><volume>73</volume><issue>12</issue><spage>1190</spage><epage>1192</epage><pages>1190-1192</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>CT scan of the chest showed features consistent with ARDS (Acute Respiratory Distress Syndrome) (figure 1B). There are reports of the successful use of all these therapies in ASSD-ILD,2–7 although the evidence is generally limited to case series. [...]we have had some success using these drugs, in other patients with less severe ASSD-ILD. Screening for ANA, anti Cyclic citrullinated peptides (anti-CCP) and autoantibodies, including antisynthetase and myositis-associated antibodies, in all patients presenting with unexplained severe respiratory failure recalcitrant to initial therapy may help in diagnosis, as peripheral clinical signs of systemic rheumatic diseases can be very subtle. S9 Acute inflammatory presentation associates with survival in interstitial lung disease and extracorporeal membrane oxygenation-requiring severe respiratory failure: a single centre case series.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>30327340</pmid><doi>10.1136/thoraxjnl-2018-212145</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0040-6376 |
| ispartof | Thorax, 2018-12, Vol.73 (12), p.1190-1192 |
| issn | 0040-6376 1468-3296 |
| language | eng |
| recordid | cdi_proquest_journals_2148767180 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Anti-Bacterial Agents - therapeutic use Antibodies, Antinuclear Antigens Autoantigens - immunology Cyclophosphamide - therapeutic use Extracorporeal Membrane Oxygenation Female Humans Immunoglobulins Immunosuppressive Agents - therapeutic use Intensive care Lung diseases Lung Diseases, Interstitial - etiology Lung Diseases, Interstitial - therapy Medical imaging Medical prognosis Middle Aged Myositis - blood Myositis - complications Myositis - diagnosis Myositis - drug therapy Ostomy Oxygen Inhalation Therapy Patients Pneumonia Respiratory Insufficiency - etiology Respiratory Insufficiency - therapy Respiratory therapy Rheumatology Ribonucleoproteins - immunology Rituximab - therapeutic use SS-B Antigen Tacrolimus - therapeutic use Ventilators |
| title | AIP, Jo-1 and ECMO |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T12%3A01%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AIP,%20Jo-1%20and%20ECMO&rft.jtitle=Thorax&rft.au=Vijayasingam,%20Anitha&rft.date=2018-12&rft.volume=73&rft.issue=12&rft.spage=1190&rft.epage=1192&rft.pages=1190-1192&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thoraxjnl-2018-212145&rft_dat=%3Cproquest_cross%3E2148767180%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2148767180&rft_id=info:pmid/30327340&rfr_iscdi=true |